🧬 Rising Oncology Drug Costs Are Hurting Your Bottom Line — Here's How to Fight Back


Oncology practices face an uphill battle: cutting-edge cancer treatments come with soaring drug costs, delayed reimbursements, and ever-changing billing regulations. The result? Strained cash flow, tighter margins, and a constant balancing act between patient care and financial health.

In our latest blog, we dive into real-world, actionable strategies that can help you:
✅ Reduce drug acquisition costs through smarter inventory and pricing
✅ Leverage biosimilars, GPOs, and assistance programs to cut expenses
✅ Maximize reimbursement with accurate coding and RCM expertise
✅ Explore revenue-boosting options like the 340B program and value-based care models

💰 Whether you're managing a large oncology group or a solo practice, these strategies are built to protect your revenue—without compromising patient outcomes.

📖 [Read the full blog] and discover how Confair helps oncologists improve financial performance while focusing on what matters most: saving lives.

Comments

Post a Comment

Popular posts from this blog

Why Outsourcing Medical Billing Might Be Your Practice’s Best Move 🚀

Image
Struggling to keep up with billing updates, denials, and compliance? You're not alone. Many doctors are discovering that outsourcing billing brings real advantages: ⏱ Faster reimbursements thanks to expert teams and streamlined workflows ✅ Improved compliance with code changes and audit safeguards 💸 Reduced overhead on staff, software, training, and error management 📈 Better transparency , with detailed reporting and analytics 🏥 More focus on care , less on claims and admin hassles Curious why so many practices are making the switch? Don’t miss the full breakdown—check out the complete post on our site! 👉 Read more
Read more

Hidden Costs of In-House Medical Billing: What Most Practices Overlook

Image
Managing your billing in-house might feel like you're in control—but is it actually costing your practice more than you think? From staff turnover and compliance gaps to escalating software expenses and slower reimbursements, in-house billing comes with its own set of challenges that aren't always visible at first glance. 🩺 Is your billing team overwhelmed? 🧾 Are denials and delays becoming routine? 📉 Could your practice benefit from specialized support? We explored all these hidden issues in our latest post. If you're a healthcare provider juggling clinical care and back-office tasks, this is a must-read. 👉 Read the full blog here
Read more

💊 Think Clinical Judgment Is Enough for Drug Delivery Decisions? Think Again.

Image
In oncology, selecting the right therapy is only half the battle. The other half? Navigating complex drug policies that dictate how and if you’ll get reimbursed. 📉 Even FDA-approved treatments can be denied if they fall outside Medicare’s Local or National Coverage Determinations (LCDs/NCDs) . ⚠️ Medicaid policies vary drastically by state — one wrong step can lead to claim denials and compliance risks . 🚫 And don’t forget commercial payers with strict carve-out rules that can block buy-and-bill entirely. If your practice isn’t aligned with these policies, you're not just risking revenue—you’re risking delays in patient care . 🧠 In our latest blog, we break down: Why LCD/NCD awareness must be part of your workflow How state Medicaid rules can impact infused drug billing What commercial pharmacy mandates mean for your procurement model And how policy non-compliance could trigger audits or non-payment ✅ Learn how top-performing oncology practices use po...
Read more